Whether you are practicing in a referral-based clinic, primary-care office, or commercial setting, we will all encounter patients with uveitis. There are a wealth of articles, studies, and lectures on how to diagnose, treat, and manage uveitis.
A recent study published in JAMA Ophthalmology found that current use of moxifloxacin (Avelox, Bayer) or ciprofloxacin (Cipro, Bayer) appears to increase the risk for uveitis.
Developing a differential diagnosis for a patient with uveitis begins by identifying known risk factors for uveitic entities. Spend the time to take a thorough history. You’ll find that the huge number of possibilities has been trimmed to a manageable number, which can then be evaluated by direct examination and laboratory testing for an underlying disease in your uveitic patient.